The mechanism by which MMP-14 could be involved in the pathogenesis of high-risk BCC is the degradation of the E-cadherin/β-catenin complex and the activation of other MMPs, such as MMP-2 [211]. The gene discussed is CDH1; the disease is skin basal cell carcinoma.